These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35240961)

  • 41. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
    Kim J; Han SH; Kim HI
    J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy.
    Cho WK; Yu JI; Park HC; Lim DH; Kim TH; Chie EK
    Tumori; 2021 Jun; 107(3):247-253. PubMed ID: 32646298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    Yoon JK; Jang JY; An YS; Lee SJ
    PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric study.
    Ricciardolo AA; De Ruvo N; Serra F; Prampolini F; Solaini L; Battisti S; Missori G; Fenocchi S; Rossi EG; Sorrentino L; Salati M; Spallanzani A; Cautero N; Pecchi A; Ercolani G; Gelmini R
    Updates Surg; 2022 Feb; 74(1):283-293. PubMed ID: 34699033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
    Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
    Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer.
    Grønberg BH; Sjøblom B; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Eur J Clin Nutr; 2019 Jul; 73(7):1069-1076. PubMed ID: 30254241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
    Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
    Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor.
    Song H; Xiao X; Liu G; Zhou J
    BMC Cancer; 2022 Feb; 22(1):179. PubMed ID: 35177018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.
    Zhang S; Tan S; Jiang Y; Xi Q; Meng Q; Zhuang Q; Han Y; Sui X; Wu G
    Clin Nutr; 2019 Dec; 38(6):2881-2888. PubMed ID: 30630709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
    Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy.
    Kurita Y; Kobayashi N; Tokuhisa M; Goto A; Kubota K; Endo I; Nakajima A; Ichikawa Y
    Pancreatology; 2019 Jan; 19(1):127-135. PubMed ID: 30473464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
    Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
    Kim EY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM
    J Thorac Oncol; 2015 Dec; 10(12):1795-9. PubMed ID: 26484630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma.
    Fukushima H; Yokoyama M; Nakanishi Y; Tobisu K; Koga F
    PLoS One; 2015; 10(1):e0115895. PubMed ID: 25612215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience.
    Zilioli VR; Albano D; Arcari A; Merli F; Coppola A; Besutti G; Marcheselli L; Gramegna D; Muzi C; Manicone M; Camalori M; Ciammella P; Colloca G; Tucci A
    J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1042-1055. PubMed ID: 34114749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sarcopenia in patients with pancreatic cancer, an independant prognostic factor].
    Mandl J; Baumer S; Holtzem B; Theurer R; Zorger N; Pech O
    Z Gastroenterol; 2023 Oct; 61(10):1365-1370. PubMed ID: 36482058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CT-Determined Sarcopenia in GLIM-Defined Malnutrition and Prediction of 6-Month Mortality in Cancer Inpatients.
    Sánchez-Torralvo FJ; Ruiz-García I; Contreras-Bolívar V; González-Almendros I; Ruiz-Vico M; Abuín-Fernández J; Barrios M; Alba E; Olveira G
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.